Fig. 5From: Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemiaAnalysis of the diagnostic value of diagnostic markers. A, B ROC curve analysis of the diagnostic value of the four diagnostic genes and the risk score in the GSE13159 (A) and GSE144119 (B) cohorts. C, D Differences in risk scores between different molecular subtypes in the GSE13159 (C) and GSE144119 (D) cohorts. E Differences in risk scores between patients who responded and did not respond to imatinib treatment in the GSE2535 cohortBack to article page